Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 14, 2016, during market hours
10-K filed Mar 15, 2016, 75 days after period end · 0000320017-16-000098
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $7.56K | $5.28K | — | $2.75M |
| Net Income | -$33.20K | -$11.61K | -$12.54K | -$15.51M |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| EPS Diluted | -$0.59 | -$0.32 | -$0.47 | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
